C
Collegium Pharmaceutical
COLL
38.620
USD
0.07
(0.18%)
مغلق
حجم التداول
3,631
الربح لكل سهم
0
العائد الربحي
0
P/E
13
حجم السوق
1,100,099,597
العنوان: Collegium Pharmaceutical
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.